SFB 914 Trafficking of Immune Cells in Inflammation, Development and Disease
print

Links and Functions

Breadcrumb Navigation


Content

Oliver Soehnlein received two prestigious awards

ESCI’s Young Investigator Award and Basic Science Award of Glaxo Smith Kline foundation

12.07.2017

soehnlein_esci2017Oliver Soehnlein, PI of project B08, recently received two prestigious awards. The Young Investigator Award of the European Society of Clinical Investigation (ESCI), which is well recognized in the community, was awarded during this year’s annual meeting in Genoa. The price was awarded in recognition of Oliver Soehnlein’s translational work in the context of myeloid cell recruitment that has led to several high impact factor publications as well as patents on small molecule inhibitors.

soehnlein_gsk2017In addition, Oliver Soehnlein received the Basic Science Award of the Glaxo Smith Kline foundation (GSK). The award ceremony was held in the Künstlerhaus in downtown Munich and was honored by a lecture delivered by Nobel laureate Prof Jules Hoffmann. Oliver’s award was given in recognition of the publication “Cathepsin G Controls Arterial But Not Venular Myeloid Cell Recruitment.” (Circulation, 2016), a study which has received great support from SFB 914.

Images | Top left: Oliver Soehnlein receiving the ESCI award in Genoa. | Bottom right: Oliver Soehnlein (right), Professor Dr. Reinhard Andreesen (left) during the GSK award ceremony.


Oliver Soehnlein, MD, PhD
DZHK Professor for Vascular Immunotherapy
German Center for Cardiovascular Research (DZHK)
Institute for Cardiovascular Prevention, LMU Munich
Pettenkoferstr. 9
80336 Munich, Germany
Oliver.Soehnlein@med.uni-muenchen.de
phone: +49 89 4400 54677


Service